微流体控装置市场规模、份额及成长分析（依产品、材料、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，全球微流体装置市场规模将达到 276.1 亿美元，到 2025 年将成长至 311.4 亿美元，到 2033 年将成长至 816.3 亿美元，预测期（2026-2033 年）的复合年增长率为 12.8%。

由于微流控装置在医疗保健、製药、生物技术和研究等领域的广泛应用，全球微流体控装置市场正经历强劲成长。这些先进的装置能够开发出紧凑且便携的诊断工具，并提供快速且准确的检测结果。将样品製备、分析和检测功能整合到单一平台上，在资源有限的环境中尤其有利。微流体技术已在医疗保健领域广泛应用，透过小型化实验室流程，提高了检测速度和效率，同时减少了样本和试剂的用量，从而革新了医学诊断。微流体检测具有快速出结果、成本节约以及能够进行多重检测等优势，显着推动了分子诊断、免疫检测、细胞分析和基因组学等领域对微流控装置的需求。

全球微流体控装置市场驱动因素

由于医疗保健、製药和生物技术等各个领域对小型便携式解决方案的需求不断增长，全球微流体控装置市场正经历显着增长。这些装置面积小、所需样品量少且功能多样，非常适合满足这项需求。微流控装置能够在微型化状态下执行复杂的实验室流程，同时兼具便携性和现场分析的可能性，这些优势正在推动微流体技术的广泛应用。这一趋势不仅提高了效率，还促进了各个领域的创新应用，从而推动了市场扩张。

全球微流体控装置市场限制因素

全球微流体控装置市场面临一些限制因素，尤其是在医疗和诊断领域以外的产业。农业、环境监测和食品检测等产业具有从微流体技术中获益的巨大潜力，但其应用推广速度仍缓慢。这种犹豫不决可归因于人们对这些创新解决方案的认知度较低、基础设施不足以及对传统方法的过度依赖。提高潜在终端用户对微流体控装置在这些尚未充分开发的领域中的众多优势和多样化应用的认知度，对于推动市场成长至关重要。

全球微流体装置市场趋势

全球微流体控装置市场正呈现强劲成长趋势，就地检验（POC​​T）应用日益普及。这些装置能够提供即时诊断结果，帮助医疗专业人员更快做出决策。它们只需少量检体即可实现快速分析，这一优势在包括医院、诊所和居家医疗在内的各种医疗环境中都备受重视。尤其是在急诊和重症监护环境中，对快速且准确诊断资讯的需求不断增长，推动了微流体技术的发展。随着医疗保健趋势向精准医疗和以患者为中心的护理模式发展，未来对微流体控装置进行高效诊断的依赖预计将进一步增加。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 原料分析

全球微流体控装置市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 微流体控装置
• 微流体组件
  • 微流体晶片
  • 流量和压力感测器
  • 流量和压力控制器
  • 微流体控阀
  • 微型帮浦
  • 微型针
  • 其他部件

全球微流体装置市场规模（按材料和复合年增长率划分）（2026-2033 年）

• 玻璃
• 硅
• 聚合物
• 其他的

全球微流体控装置市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 体外诊断
  • 临床诊断
  • 就地检验
  • 兽医诊断
• 製药与生命科学研究与製造
  • 实验室分析
  • 微量点胶
  • 微反应
• 治疗药物
  • 药物输送
  • 穿戴式装置

全球微流体控装置市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 研究所
• 诊断中心
• 医疗设施及其他

全球微流体控装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Bio-Rad Laboratories（USA）
• Illumina（USA）
• PerkinElmer（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• bioMerieux（France）
• Danaher Corporation（USA）
• Agilent Technologies（USA）
• Sphere Fluidics（UK）
• Standard BioTools（formerly Fluidigm Corporation）（USA）
• BD（Becton, Dickinson and Company）（USA）
• IDEX Corporation（USA）
• SMC Corporation（Japan）
• Parker Hannifin Corporation（USA）
• Fortive Corporation（USA）
• Aignep SpA（Italy）
• Lonza Group（Switzerland）
• Emulate（USA）
• Dolomite Bio（UK）

结论与建议

Global Microfluidic Devices Market size was valued at USD 27.61 Billion in 2024 and is poised to grow from USD 31.14 Billion in 2025 to USD 81.63 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The market for global microfluidic devices is experiencing robust growth, driven by diverse applications across healthcare, pharmaceuticals, biotechnology, and research sectors. These advanced devices facilitate the creation of compact, portable diagnostic tools that provide rapid and precise results. By integrating functions such as sample preparation, analysis, and detection on a single platform, they are particularly beneficial for resource-limited environments. The healthcare sector has embraced microfluidic technology, transforming medical diagnostics through miniaturized laboratory processes that reduce sample and reagent volumes while enhancing testing speed and efficiency. Microfluidic assays deliver advantages like quicker turnaround times, decreased costs, and the capability for multiplex testing, significantly boosting demand for devices used in molecular diagnostics, immunoassays, cell analysis, and genomics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Devices Market Segments Analysis

Global Microfluidic Devices Market is segmented by Product, Material, Application, End User and region. Based on Product, the market is segmented into Microfluidic-based Devices and Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer and Others. Based on Application, the market is segmented into In-vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, Diagnostic Centers and Healthcare Facilities and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Devices Market

The global microfluidic devices market is experiencing significant growth due to a rising demand for compact and portable solutions across diverse sectors such as healthcare, pharmaceuticals, and biotechnology. These devices excel in addressing this need because of their small footprint, minimal sample size requirements, and multifunctional capabilities. Their ability to conduct intricate laboratory processes in a scaled-down format, coupled with the ease of portability and the potential for on-site analysis, is propelling the widespread adoption of microfluidic technology. This trend is not only enhancing efficiency but also fostering innovative applications across various fields, thereby driving market expansion.

Restraints in the Global Microfluidic Devices Market

The Global Microfluidic Devices market encounters certain restraints, particularly in sectors beyond healthcare and diagnostics. Industries such as agriculture, environmental monitoring, and food testing have the potential to greatly benefit from microfluidic technologies; however, their adoption remains sluggish. This hesitance can be attributed to limited awareness of these innovative solutions, insufficient infrastructure, and a strong dependency on traditional methods. To foster market growth, it is essential to enhance awareness and provide education to potential end-users regarding the numerous advantages and diverse applications of microfluidic devices in these underexplored sectors.

Market Trends of the Global Microfluidic Devices Market

The Global Microfluidic Devices market is witnessing a robust trend towards the increasing adoption of point-of-care testing (POCT) applications. These devices excel in providing immediate diagnostic results, facilitating prompt decision-making by healthcare professionals. Their ability to process small sample volumes and deliver rapid analyses makes them highly valued in diverse healthcare environments, including hospitals, clinics, and home care settings. The demand for swift and accurate diagnostic information, particularly in emergency and critical care scenarios, is propelling the growth of microfluidic technologies. As healthcare trends evolve towards precision medicine and patient-centered care, the reliance on microfluidic devices for efficient diagnostics is expected to surge.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Microfluidic Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Microfluidic-based Devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

Global Microfluidic Devices Market Size by Material & CAGR (2026-2033)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Global Microfluidic Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearables Devices

Global Microfluidic Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Diagnostic Centers
• Healthcare Facilities and Others

Global Microfluidic Devices Market Size & CAGR (2026-2033)

• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sphere Fluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools (formerly Fluidigm Corporation) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Bio (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations